Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter
ByAinvest
Tuesday, Jan 6, 2026 8:04 am ET1min read
STXS--
Stereotaxis has received FDA approval for its MAGiC Magnetic Interventional Ablation Catheter, which is designed for robotic cardiac ablation procedures that treat heart arrhythmia. The catheter is navigated by magnetic fields and offers improved precision and stability compared to traditional catheters. This approval is expected to expand access to minimally-invasive cardiac ablation therapy for complex patient populations.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet